SIMPLEX TRADING, LLC - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 153 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2016. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$1
-94.4%
757
-85.9%
0.00%
Q2 2023$18
-43.8%
5,350
-48.4%
0.00%
Q1 2023$32
-99.9%
10,367
-35.0%
0.00%
Q3 2022$37,000
+311.1%
15,946
+360.5%
0.00%
Q2 2022$9,000
-96.2%
3,463
-95.6%
0.00%
Q4 2021$238,000
+891.7%
78,512
+2871.7%
0.00%
Q3 2021$24,0000.0%2,6420.0%0.00%
Q2 2021$24,000
-79.7%
2,642
-81.2%
0.00%
Q1 2020$118,000
-81.2%
14,039
-80.4%
0.00%
-100.0%
Q4 2019$626,000
+1638.9%
71,650
+2003.0%
0.00%
Q3 2019$36,000
-78.3%
3,407
-74.0%
0.00%
Q2 2019$166,000
-46.6%
13,123
+63.4%
0.00%
-100.0%
Q1 2019$311,000
-55.9%
8,031
-76.9%
0.00%
-50.0%
Q4 2018$706,000
+132.2%
34,716
+423.5%
0.00%
+100.0%
Q3 2018$304,000
-72.4%
6,632
-64.4%
0.00%
-75.0%
Q2 2018$1,101,000
+228.7%
18,629
+448.7%
0.00%
-71.4%
Q4 2017$335,000
-74.0%
3,395
-77.0%
0.01%
-75.0%
Q2 2017$1,289,000
+522.7%
14,757
+163.9%
0.06%
+522.2%
Q1 2017$207,000
-81.7%
5,591
-67.0%
0.01%
-88.3%
Q3 2016$1,134,000
+368.6%
16,918
+107.6%
0.08%
+381.2%
Q2 2016$242,000
-34.2%
8,148
-35.1%
0.02%
-44.8%
Q1 2016$368,000
-60.9%
12,558
+4.7%
0.03%
-60.8%
Q4 2015$940,000
+27.2%
11,991
+22.2%
0.07%
+37.0%
Q3 2015$739,000
+31.5%
9,810
+103.8%
0.05%
+14.9%
Q2 2015$562,000
+39.8%
4,814
+182.5%
0.05%0.0%
Q1 2015$402,000
+91.4%
1,704
+53.7%
0.05%
+88.0%
Q4 2014$210,0001,1090.02%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q3 2016
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 1,792,114$4,713,2604.15%
Eversept Partners, LP 1,681,149$4,421,4220.37%
Camber Capital Management LP 4,235,000$11,1380.37%
Kynam Capital Management, LP 473,975$1,246,5540.20%
GLOBEFLEX CAPITAL L P 538,559$1,416,4100.17%
Affinity Asset Advisors, LLC 202,349$532,1780.15%
GSA CAPITAL PARTNERS LLP 279,629$7350.06%
RICE HALL JAMES & ASSOCIATES, LLC 363,666$956,4420.06%
Patriot Financial Group Insurance Agency, LLC 67,000$176,2100.04%
ACADIAN ASSET MANAGEMENT LLC 1,858,000$4,8840.02%
View complete list of PUMA BIOTECHNOLOGY INC shareholders